Patron Exim is in the trading/distribution sector only and it doesn’t engage in the manufacturing process.
New Delhi: Ahmedabad-based company Patron Exim, which engages in the trading and distribution of a wide range of pharmaceutical raw materials which is known as APIs (Active Pharmaceutical Ingredients), industrial chemicals, excipients, and solvents, has opened its initial public offering (IPO) today, 21 February 2023.
Also Read– United Breweries, ACC, Ambuja Cement, Asian Paints, Bharat Electronics, BEML stocks in focus
Patron Exim is in the trading/distribution sector only and it doesn’t engage in the manufacturing process. The Ahmedabad-based company is a member of a large group of businesses that also includes Cedac Medicorp, Evoque Remedies, Earum Pharmaceuticals, Auxilia Pharmaceuticals, Madrid Diamonds, Atlantis Exim, N G Overseas, and many others. The Group of Companies operates primarily in the pharmaceutical, chemical industries and adjacent industries.
As of Tuesday, 3 pm, the Non-Institutional Investors (NII) category has been subscribed 0.01 times and retail portion has been subscribed 0.15 times.
Read More: How to use credit card to make UPI payments
| IPO Date | 21 February 2023 to 24 February 2023 |
| Listing Date | 6 March 2023 (Tentative) |
| Face Value | Rs 10 per share |
| Price | Rs 27 per share |
| Lot Size | 4000 shares |
| Issue Size | 6,180,000 shares of Rs 10 (aggregating up to Rs 16.69 Cr) |
| Fresh Issue | 6,180,000 shares of Rs 10 (aggregating up to Rs 16.69 Cr) |
| Market Maker portion | 316,000 shares |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| P/E (x) | Rs 11.25 Cr |
| Market Cap | Rs 62.59 Cr |
| NII (HNI) Shares Offered | 50 per cent of the Net Issue |
| Retail Shares Offered | 50 per cent of the Net Issue |
| Market Maker | SUNFLOWER BROKING PVT. LTD. |
| Company Promoters | Mr. Narendrakumar Gangaramdas Patel and Mrs. Sushilabahen Narendrakumar Patel are the promoters of the company. |
Read More: How Post Office Monthly Pension Scheme Secures A Depositor Financially
When it comes to promoter shareholding, the pre-issue shareholding is 97.6 per cent, and post the issue, the promoter shareholding will be 71.18 per cent.
